Jeffrey A. Bailey - 04 Nov 2021 Form 4 Insider Report for BIODELIVERY SCIENCES INTERNATIONAL INC

Role
Chief Executive Officer, Director
Signature
Jeffrey A Bailey
Issuer symbol
N/A
Transactions as of
04 Nov 2021
Net transactions value
$0
Form type
4
Filing time
08 Nov 2021, 15:40:42 UTC
Previous filing
10 Aug 2021
Next filing
31 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BDSI Common Stock Options Exercise $0 +53,333 +115% $0.000000 99,800 04 Nov 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDSI Restricted Stock Units Options Exercise $0 -53,333 -33% $0.000000 106,667 04 Nov 2021 Common Stock 53,333 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units ("RSUs") granted to the Reporting Person on November 4, 2020, under the Issuer's 2019 Stock Option Incentive Plan. The remaining RSUs vest equally on November 4, 2022 and November 4, 2023.